OREANDA-NEWS. OJSC Pharmacy Chain 36.6 [RTS:APTK; MICEX:RU14APTK1007], the leading Russian pharmaceutical retailer, announces unaudited sales and operational results for 1Q 2013 according to the management accounts.

GROUP SALES :

- Group’s consolidated Net sales reached RUR 5 015 mln in 1Q 2013 which is a 9% decrease in ruble terms y-o-y;

- Pharmacy Retail Net Sales reached RUR 3 642 mln in 1Q 2013 which is a 2% decrease in ruble terms y-o-y;

- Net Sales of finished goods of the production unit Veropharm reached RUR 1 200 mln in 1Q 2013;

- Non-core business Net sales in 1Q 2013 reached RUR 193 mln.

SALES:

- As of the 31st of March 2013 Pharmacy Chain 36.6 operated 777 stores in 24 regions of Russia. During first 3M 2013 5 stores were opened organically and 70 were closed;

- As of the 31st of March 2013 Pharmacy Chain 36.6 operated 8 stand-alone optical outlets and 24 additional optical departments within pharmacies.

- Sales growth in 1Q 2013 at LEKO reached 14% in y-o-y terms. Consumer traffic in 1Q 2013 increased by 8% at ‘LEKO’ stores in y-o-y terms. As of the 31st of March 2013 Pharmacy Chain 36.6 operated 155 ‘Leko’ stores.

- Like-for-like sales in 1Q 2013 reached RUR 3 073 mln versus RUR 3 076 mln in 1Q 2012, average ticket in 1Q 2013 reached RUR 416 (+8% in y-o-y terms). As of the end of 1Q 2013 Pharmacy Chain 36.6 operates 536 like-for-like stores.

PRIVATE LABEL:

- In 1Q 2013 the private label sales increased by 16% in y-o-y terms and reached RUR 666 mln;

- In 1Q 2013 a share of private label sales in the total retail pharmacy sales reached 18%;

- Number of SKUs in active portfolio increased by 2 803 SKU.